Publications

Lipid Nanoparticles for Organ-Specific mRNA Therapeutic Delivery

Direct Reprogramming Induces Vascular Regeneration Post Muscle Ischemic Injury

Therapeutic Delivery of Pip4k2c‐Modified mRNA Attenuates Cardiac Hypertrophy and Fibrosis in the Failing Heart

Modified mRNA as a Therapeutic Tool for the Heart

Delivery of Modified mRNA in a Myocardial Infarction Mouse Model

Optimization of 5′ Untranslated Region of Modified mRNA for Use in Cardiac or Hepatic Ischemic Injury

Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration

Altering Sphingolipid Metabolism Attenuates Cell Death and Inflammatory Response After Myocardial Infarction

Optimizing Modified mRNA In Vitro Synthesis Protocol for Heart Gene Therapy

mRNA-Based Protein Replacement Therapy for the Heart

Ablation of a Single N-Glycosylation Site in Human FSTL 1 Induces Cardiomyocyte Proliferation and Cardiac Regeneration

Synthesis of Modified mRNA for Myocardial Delivery

Contact Us

Office
1470 Madison Ave. Floor 7 Room 107
Phone: (212) 824-8915

Laboratory

1470 Madison Ave. Floor 7 Room 301
New York, NY 10029

Phone: (212) 824-9013